Thye Dirk insider trades
Thye Dirk has filed 12 Form 4s with the SEC that we hold, all for Quince Therapeutics, Inc. (QNCX), as CEO and CMO, Director. Across all of them we count 4 purchases worth $317.5K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 88,000 shares of Quince Therapeutics, Inc. worth $110.9K, dated 2023-08-10. The first filing on our record is dated 2022-05-23 and the latest 2026-01-23.
Quince Therapeutics, Inc. (QNCX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-08 | P, purchase reported on Form 4 | 80,000 | $99.2K | 2023-08-09 |
| 2023-08-10 | P, purchase reported on Form 4 | 88,000 | $110.9K | 2023-08-11 |
| 2024-08-29 | P, purchase reported on Form 4 | 77,500 | $53.5K | 2024-09-03 |
| 2024-08-30 | P, purchase reported on Form 4 | 77,000 | $53.9K | 2024-09-03 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1638945) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms